Pages
Posts by category
- Category: Awards
- Dan Shea & Channing Hamlet Named 2023 Finance Visionaries by the Los Angeles Times
- Dan Shea & Channing Hamlet Named 2022 Leaders of Influence: Investment Bankers by Los Angeles Business Journal
- Channing Hamlet and Dan Shea Named Leaders of Influence: Investment Bankers 2021 By The Los Angeles Business Journal
- Objective Awarded The 2020 Corporate/Strategic Deal of the Year by The M&A Advisor
- Objective Named a Top 100 “Best Places to Work” in San Diego 2020
- Objective Capital Partners Named a Top 100 “Best Places to Work” in San Diego 2019
- David H. Crean Elected as President of the Association for Corporate Growth, San Diego
- Objective Capital Partners Recognized for 2019 Corporate/Strategic Deal of the Year
- Objective Capital Partners Managing Partner, Trever F. Acers, Named in The San Diego 500 for 2018
- OCP Named Finalist for Valuation Firm of The Year
- Objective Capital’s David H. Crean Receives The 2018 Health Care Heros Award
- Objective Capital’s David H. Crean Named 2017 Thought Leader of the Year
- Objective Capital Partners Trever Acers Honored in 2018 San Diego’s 500 Influential Business Leader List
- Objective Capital’s David H. Crean Named 2017 Finalist for Thought Leader of the Year
- Objective Capital Partners Wins Four Awards at Advisor of the Year 2017
- Objective Capital Partners Announced as Finalist in Seven Categories for Advisor of the Year Awards
- M&A Deal Represented by Objective Capital Partners Selected as Finalist by The M&A Advisor
- Objective Capital Partners Announced as Finalist for Boutique Investment Banking Firm of the Year
- Objective Capital Partners Trever Acers Honored in 2016 San Diego’s 500 Influential List
- Objective Capital Wins Four Awards At 2016 Advisor of the Year
- Objective Capital Partners Announced as Finalist for Advisor of the Year Awards
- Objective Capital Partners 15th Annual M&A Advisor Awards Finalist
- Michael Kim Announced as Winner of the 7th Annual Emerging Leaders Award
- Objective Capital Partners Announced as Finalist For Advisor of the Year Awards
- Category: Business Services
- Healthcare SaaS M&A Industry Update | Septemeber 2023
- Healthcare Digital Marketing M&A Industry Update | September 2023
- Diagnostics & Testing M&A Industry Update | September 2023
- Contract Research Organization M&A Industry Update | September 2023
- Contract Research Organization M&A Industry Update | July 2023
- Healthcare Digital Marketing M&A Industry Update | July 2023
- Healthcare SaaS M&A Industry Update | June 2023
- Objective Advises Imagine Reporting on its Sale to Lexitas
- Contract Research Organization M&A Industry Update | May 2023
- What is Your ‘Why’ in Seeking a Transaction for Growth or Exit?
- Selling Your Company: How to Respond to An Unsolicited Offer to Buy Your Business
- Business Services Industry Report | 2021 Year In Review
- Objective, Investment Banking & Valuation Advises Sale of Rocky Mountain Movement Disorders Center to CenExel Clinical Research
- Business Services Industry Report | Q1 2021
- How to Walk Away From Every Networking Event With New Connections
- Contract Research Organization Industry Report: 2019 Review
- How To Formulate a Thoughtful List of Acquirers
- Is Your Company Ready for Sale?
- Human Capital Services Active Acquirer Report Q3 2019
- IT Services Active Acquirer Report Q3 2019
- Insurance Services Active Acquirer Report Q3 2019
- Transportation & Logistics Active Acquirer Report Q3 2019
- Building Services Active Acquirer Report Q3 2019
- OCP Advises Sale of Carl Warren to Claims Technology Group of America
- Look Beyond the Obvious Acquirer for Your Business
- Develop Your Financing Strategy to Attract Capital and Move Beyond Your Initial Seed Stage
- Bio Buck$ Fast Forward: A Start-up’s Guide to Investment Banks
- Objective Capital Partners Trever Acers to Address Company Needs for Obtaining Capital at the CFO Leadership Council
- Objective Capital Partners Expands its Investment Banking Practice to Serve Owners of Lower Middle Market Companies
- Manage Your Business to Achieve Maximum Price When You Sell
- Objective Capital Partners Offers Business Valuation Services to Portfolio of Offerings
- Category: Business Valuation
- Maximizing Equitable Division in Divorce: The Unseen Value in Business and Intellectual Property Valuation
- Mastering Your Exit: A Comprehensive Guide to your Business Exit Options
- Navigating the Rising Tide: How Interest Rates Shape Company Valuations and Investment Strategies
- What Is the Right Methodology for Your Business Valuation?
- Valuing Your Business for Estate Planning and Gift Purposes
- Considerations For Repricing Your Stock Option Grants
- Business Bros Podcast Episode Featuring Channing Hamlet
- Scale Up Podcast Episode with Nick Bradley Featuring Channing Hamlet
- Selling a Business? Learn How to Not Leave Money On The Table
- Objective, Investment Banking & Valuation Completes Fairness Opinion to Ra Medical Systems, Inc. (NYSEAM: RMED)
- The Deal Scout With Josh Wilson Podcast Episode Featuring Channing Hamlet
- Selling Your Business with David King Podcast Episode Featuring Channing Hamlet
- Mission Matters Podcast Episode with Jeffrey Brewster
- IRS Memorandum: Reiterates Importance of Pending Events in Valuations
- Objective Expands Its Valuation Practice with New Managing Director, Jeffrey Brewster, CFA, CVA
- Objective Welcomes New Senior Associate, Valuation, Adam Schechtman
- Trever Acers and David Crean Recognized As Most Influential Leaders In The SD 500 2020 by the San Diego Business Journal
- Channing Hamlet and Dan Shea Named Leaders of Influence 2020: Investment Bankers By The Los Angeles Business Journal
- Objective Bolsters Its Execution Power with New Valuation Associate, Derrick Turnbow
- Estate Planning Opportunities: How to Safeguard Assets in Turbulent Times
- The Guide to Financial Instruments: Recognition and Measurement of Financial Assets and Liabilities
- Monthly Transaction Monitor | September 2020
- Top 10 Reasons You Might Need a Business Valuation
- Christian Dougherty Joins OCP As Managing Director, Valuation Advisory Services
- 2019 Life Science and Healthcare Market Trends
- Life Science Entrepreneurs Looking for Strategic Investments
- How Family Offices Should Approach Investment in the Life Sciences and Healthcare Industry
- OCP Is Leading Growth in the San Diego Life Science Community
- Presentation Guide for Life Science Companies
- A Roundtable for Life Science Executives: Private Capital Raising
- Anatomy of a 409a Valuation & Methodology
- The Value of Investment Bankers in Company Sale Transactions
- Category: Buy-Side M&A
- An Existing Shareholder Wants To Buy The Business. Now What?
- SoCal Capital Summit on M&A Healthcare Trends & Opportunities
- NRC Health and Practicing Excellence Form Strategic Alliance
- Global Health Solutions Retains Objective Capital Partners As Exclusive Advisor for Acquiring Strategic Partnerships
- Objective Capital Partners Channing Hamlet to Address Mergers & Acquisitions in Today’s Economic Environment
- It’s All About the Exit -A Fireside Chat With Bob Nascenzi and Objective Capital’s Trever Acers
- Featured in Mergers & Acquisitions Magazine
- Category: Capital Raise
- Category: Consumer
- The LA Times Beauty, Fashion & Consumer Goods Roundtable with Trever Acers
- Consumer Apparel M&A Industry Update | Q1 2022
- Consumer Industry Report | 1H 2021
- Recreation Active Acquirer Report of Q2 2019
- Pet Products & Services Active Acquirer Report of Q2 2019
- Apparel & Retail Active Acquirer Report of Q2 2019
- Food & Beverage Active Acquirer Report of Q2 2019
- Health & Beauty Active Acquirer Report of Q2 2019
- Category: Healthcare
- CRO Report: Q3 20 & Beyond
- Objective Capital Partners Advises Sale of Bell Canyon Consulting to TRINITY
- PermeaDerm, Inc. Completes Sale to Stedical Scientific
- Healthcare & Life Sciences Tech Active Acquirer Report Q2 2019
- CRO Sector Fundamentals Remain Hot for M&A Consolidation
- M&A in Fertility Outpatient Care Centers Remains Strong
- High Cost of R&D Innovation in Healthcare
- The Investment Landscape in Cannabis for Healthcare Applications
- Ravin S. Bisla Joins OCP as Director in Healthcare Sector
- Matthew J. Pelo Joins OCP As Vice President
- Objective Capital Advises Healthcare IT Company on Its Sale to Kinderhook Industries
- Symple Surgical, Inc. Retains Objective Capital Partners to Explore Strategic and Financial Partnerships
- Life Sciences Tools, Diagnostics, & Services Industry Report 11/2017
- The Math Behind the Aftermath Driving a Private-Public Merger Transaction: Mast Therapeutics and Savara
- Objective Capital Partners Strengthens Its Healthcare & Life Sciences Investment Banking Practice with the Addition of Jack J. Florio
- Objective Capital Partners Adds CardioCell to Expanding Portfolio of Life Science Companies
- Objective Capital Partners Retained by Marina Biotech to Explore Strategic Alternatives
- AVACEN Medical Inc. Retains Objective Capital Partners
- Objective Capital Partners Establishes Life Sciences Practice – Adds David H. Crean, Ph.D as a Managing Director
- Category: Insights
- Engineered Components M&A Industry Update | September 2023
- Chinese Manufacturing Moving Away from China – What Does it Mean for Your Business?
- Engineered Components M&A Industry Update | June 2023
- Engineered Components M&A Industry Update | April 2023
- The Difference Between Strategic and Financial Acquirers
- Engineered Components M&A Industry Update | Feb 2023
- San Diego Success Stories Featuring ProEst with Tech San Diego
- SaaS M&A Industry Update | Nov 2022
- Essential Services M&A Industry Update | Nov 2022
- SaaS M&A Industry Update | Oct 2022
- Engineered Components M&A Industry Update | Sep 2022
- SaaS M&A Industry Update | July 2022
- Engineered Components M&A Industry Update | July 2022
- Engineered Components M&A Transaction Monitor | May 2022
- Technology Industry Report | Q1-Q3 2021 SaaS Market Report
- CRO Report: CRO’s Are Positioned For Accelerating Growth
- Monthly Transaction Monitor | August 2020
- Tax Planning Q&A: 1H 2020 & Beyond
- Objective Capital Partners Advises Adoption of Shareholder Rights Plan by RCM Technologies
- Shareholder Rights Plans Guide to Resurgence
- M&A Remains Strong Amid COVID-19 In Certain Industry Segments
- How to Build and Maintain Your Network During an Age of Social Distancing
- Objective Capital Partners Advises Sale of ePlastics® to Laird Plastics, Inc.
- COVID-19 Update: Economic Impact, Biopharma Response, and Consequences
- Is Your Business Prepared For An Economic Downturn?
- David H. Crean, Ph.D Named San Diego Top 500 Most Influential Business Leader 2020
- Trever F. Acers Named San Diego Top 500 Most Influential Business Leader for Fifth Consecutive Year
- How To Determine Your Company’s Worth And Increase Its Value
- Objective Capital Partners Advises Sale of Toft Group to ZRG Partners
- Fertility Industry Report: 2019 Review
- Genomics Industry Report: 2019 Review
- Objective Capital Partners Managing Director Selected to Forbes Los Angeles Business Council
- Private Equity 101: What To Do When Private Equity Starts Calling
- SaaS Active Acquirer Report Q2 2019
- Digital Media & Marketing Active Acquirer Report Q2 2019
- Objective Capital Advises MabVax Therapeutics on its Sale of Assets to BioNTech
- Objective Capital Partners Launches New, Expanded Website
- How To Navigate Investment Banking Fees
- Category: Life Sciences
- Category: Manufacturing & Distribution
- Category: News & Updates
- Objective, Investment Banking & Valuation Advises on Sale of Supreme Optimization to Trinity Hunt Partners
- SaaS M&A Industry Update | 2022 in Review
- Objective, Investment Banking & Valuation Advises on Sale of Beacon Mobile to DRB®
- Objective, Investment Banking & Valuation Advises Sale of Kirei to Carnegie Fabrics
- Objective, Investment Banking & Valuation Advises Sale of ProEst to Autodesk, Inc.
- Objective, Investment Banking & Valuation Advises Sale of AEM to Industrial Growth Partners
- Objective Welcomes New Investment Banking Analyst Hanna Templin
- Objective Welcomes New Investment Banking Analyst Cameron Peck
- Objective, Investment Banking & Valuation Advises Sale of Kindred Bravely to TZP Group
- Objective Capital Partners Advises Sale of Myers Media Group to Resurgent Capital Partners
- Objective Capital Partners Strengthens Its M&A Leadership with New Managing Director Daniel Shea
- Objective Capital Partners Strengthens Its Execution Capability with New Managing Director Carl Miller
- Objective Capital Partners Grows Its Valuation Practice With The Addition of Mark Sadauski, CMA, CVA
- OCP Advises Everyone Counts on its Sale to Votem
- Objective Capital Partners Welcomes Matt Ramirez as Associate
- Objective Capital Partners Promotes Michael Kim to Managing Director
- Community Insights: Understand Options for Your Business
- Channing Hamlet to Keynote “What’s Your Business Really Worth?”
- Weaver Leather, LLC, Acquires Troxel Helmets
- Cagan McAfee Capital Partners Teams with Myles Sherman
- Trever Acers to Share Business Exit Strategies At ACG
- Cannon Safe Announces Partnership with MidOcean Partners To Acquire Stack-On Products
- ACG San Diego Elects OCPs’ Crean to Its Board of Directors
- Business Exit Planning, Getting a Business Ready for Sale and Building Business Value
- Important Considerations in the Sale of Your Clients Business
- Objective Capital’s Dr. David Crean to Address Entrepreneurs on Due Diligence Issues
- ACG San Diego Private Capital Expo: Healthcare
- Objective Capital Opens Los Angeles Office
- Trever Acers Joins San Diego Venture Group Board of Directors
- San Diego Venture Group (SDVG) Adds Trever Acers to Its Board of Directors
- Objective Capital Partners Expands to a New Facility
- Objective Capital Partners Adds John Lee as Vice President
- Objective Capital Partners Adds to Its Execution Power
- Objective Capital Partners Advises Del Mar Recovery Solutions on Strategic Investment by TZP Growth Partners
- Channing Hamlet of Objective Capital Partners to Address Important Considerations in the Sale of Your Clients Business at Southern California Institute
- Regen BioPharma, Inc. Retains Objective Capital Partners, LLC To Explore Non-Dilutive Funding Opportunities
- Objective Capital Partners Advises Marina Biotech on Creating Greater Shareholder Value with the Addition of a Late Stage Clinical Asset
- Objective Capital Partners Closes Deal Capitalization on Tavern+Bowl
- Objective Capital Partners Adds Michael Kim as Vice President
- Objective Capital Completes Sale of Electronic Control Systems to Albireo Energy
- Category: Sell-Side M&A
- Category: Strategic Advisory
- Category: Technology
- Category: Uncategorized
- Category: Videos
Categories
Tags
Archives
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- August 2022
- July 2022
- May 2022
- April 2022
- January 2022
- December 2021
- November 2021
- September 2021
- June 2021
- May 2021
- April 2021
- February 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- June 2020
- May 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- February 2016
- October 2015
- September 2015
- November 2014
Authors
Portfolio
- Carl Warren
- Straye Footwear
- Myers Media
- Flex Dental
- JCB Insurance
- Marketing Instincts
- Kindred Bravely
- StudyKIK
- Symple Surgical
- Viracta Therapeutics
- WES Pharma Inc.
- Beverly Hills Cancer Center
- Regen BioSciences
- Practicing Excellence
- PolyModal BioSciences
- Olivio Labs
- Nutrasumma
- ACEA Biosciences
- La Vita Compounding Pharmacy
- CardioCell
- Avacen
- APstem Therapeutics
- Amydis Diagnostics
- EveryoneCounts - Votem
- Mid - Cagan Mcafee
- MidOcean - Cannon - GunVault - Stack-On
- Z57 - Constellation Software Inc
- Seawind Foods - Tiderock
- Proximetry - Thales
- One Diamond Electronics - White Oaks
- HART - HIG
- ECS - Albireo
- Allergan - Pierre Fabre
- Allergan - Daiichi-Sankyo
- Aqua - Aptalis
- Aqua - Allergan
- Aqua - Actavis
- Allergan - Valeant
- Allergan - Stiefel
- Allergan - SkinMedica
- Allergan - Senju
- Allergan - Sanwa Kagaku Kenkyusho
- Allergan - Kyorin
- Allergan - GSK
- Allergan - Elizabeth Arden
- Allergan - Daewoong
- Allergan - Clinique
- Allergan - BARD
- Allergan - QLT
- Allergan - MAP
- Tula - Ergobaby
- The Honest Kitchen
- Suneva
- Solstice Biologics
- Skill Storm
- Romio
- Prolifiq
- Power Direct
- Perfect Point
- Escondido Metal Supply
- Ambry Genetics
- The Backplane Inc
- Tealium
- Stemedica
- Smartzip Analytics
- SG Biofuels
- Media Properties Holdings
- Nextivity
- Nanosys
- Micropower Technologies
- MedImpact
- Marqeta
- Independa
- Human Longevity Inc
- Gunnar Optiks
- Gigwalk
- FGI Finance
- Eventful
- Elcelyx Therapeutics
- Edmodo
- ecoATM
- Dubuis Health System
- Daylight Solutions
- Datastax
- Coronado Biosciences
- Capsilon
- Bump Network
- Break Media
- BioNano Genomics
- Billfloat
- Atieva
- AltheaDX
- All Clear ID
- Acacia
- Ablative Solutions
- Planck Aerosystems
- ZS Pharma
- Zogenix
- Tobira Therapeutics
- Receptos
- Otonomy
- Auspex Pharmaceuticals
- Ambit
- Zeeto Media
- Montesquieu
- Emerald Textiles
- Tumblr
- ROX Medical
- Transaction Wireless
- Verdezyne